Lasola, Emie .
HRN: 11-97-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
MUPIROCIN 2%, 15G (TUBE)
11/22/2023
11/29/2023
TOPICAL
Apply On Affected Area
BID
Abrasion On Keft Knee
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes